Literature DB >> 25224447

Bladder cancer: benefits of trimodal OMC regimen.

Robert Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25224447     DOI： 10.1038/nrurol.2014.258

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.

Authors:  Haruhito Azuma; Teruo Inamoto; Naokazu Ibuki; Takanobu Ubai; Yatsugu Kotake; Kiyoshi Takahara; Satoshi Kiyama; Hayahito Nomi; Hiroshi Uehara; Kazumasa Komura; Kazuhiro Yamamoto; Yoshihumi Narumi; Yoji Katsuoka
Journal:  Int J Oncol       Date:  2010-10       Impact factor: 5.650
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.